FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2788848192> ?p ?o ?g. }

• W2788848192 endingPage "194" @default.
• W2788848192 startingPage "189" @default.
• W2788848192 abstract "Chronic kidney disease (CKD) is a global health problem with an increasing prevalence worldwide. Anemia is one of its consistent and severe hematological complications although its mechanism is not fully elucidated. The primary defect could manifest as serum erythropoietin (sEPO) deficiency or EPO resistance. We set out to determine the erythropoietic response to anemia of patients with CKD and its relationship with their iron status in a cross-sectional descriptive study of 91 patients in various stages of CKD. Materials and Methods: Soluble transferrin receptor (sTfR), sEpo, and serum ferritin levels were determined using ELISA method (Diagnostic Automation Inc and WKEA med supplies corp.). Data generated were analyzed using Epi Info version 3.5.3 and level of statistical significance was set at ≤0.05. Results: Participants comprised of 50 females (54.9%) and 41 (45.1%) males with an overall mean age of 47 ± 15 years. The major causes of CKD were hypertension (HTN) (50.54%), diabetes mellitus (DM) (6.59%), and HTN + DM (19.78%). The mean hemoglobin (Hb) concentration of the participants was 10.97 ± 2.28 g/dl; the red cell indices were within normal ranges except for Red cell distribution width-Coefficient of variation (%) which was elevated (16.29%). The mean serum ferritin, sTfR, and sEpo were 70.58 ± 46.44 ng/ml (interquartile range [IQR] 82.00), 22.9 ± 49.7 ng/ml (IQR 15.00), and 12.49 ± 33.47 IU/L (IQR 6.00), respectively, with a high variance. Serum ferritin and sTfR are consistently low across the stages of CKD (range between 54.54 ng/ml and 88.64 ng/ml), but sEPO for stage 3 and 4 showed a 2-fold increase when compared to normal level at Hb 10.97 g/dl (29.54 IU/L and 38.83 IU/L, respectively). Correlation between sTfR and sEpo (r2 = 0.96, P = 0.001), while between sEpo and serum ferritin (r2 = 0.02, P = 0.185), and between Hb and stage of CKD undulating (r2 = 0.41, P = 0.001).In contrast to some existing literature, this study has demonstrated that EPO resistance and iron deficiency contributes to anemia in CKD and serum ferritin can be used to assess the iron level of dialysis naïve CKD patients at every stage of the disease." @default.
• W2788848192 created "2018-03-06" @default.
• W2788848192 creator A5009424032 @default.
• W2788848192 creator A5014640819 @default.
• W2788848192 creator A5031091926 @default.
• W2788848192 creator A5036161581 @default.
• W2788848192 creator A5038550193 @default.
• W2788848192 creator A5042747733 @default.
• W2788848192 creator A5070994957 @default.
• W2788848192 creator A5086140142 @default.
• W2788848192 date "2018-02-01" @default.
• W2788848192 modified "2023-09-23" @default.
• W2788848192 title "Erythropoietic Response to Anaemia of Dialysis Naïve Patients with Chronic Kidney Disease in Zaria, North-West Nigeria." @default.
• W2788848192 cites W1499359442 @default.
• W2788848192 cites W169281302 @default.
• W2788848192 cites W1968068367 @default.
• W2788848192 cites W1972226511 @default.
• W2788848192 cites W1976024031 @default.
• W2788848192 cites W1984519576 @default.
• W2788848192 cites W2009643755 @default.
• W2788848192 cites W2012325375 @default.
• W2788848192 cites W2051175680 @default.
• W2788848192 cites W2055607907 @default.
• W2788848192 cites W2062050844 @default.
• W2788848192 cites W2078288049 @default.
• W2788848192 cites W2088779243 @default.
• W2788848192 cites W2098124630 @default.
• W2788848192 cites W2102785833 @default.
• W2788848192 cites W2113333134 @default.
• W2788848192 cites W2115870410 @default.
• W2788848192 cites W2117766441 @default.
• W2788848192 cites W2120601666 @default.
• W2788848192 cites W2146878735 @default.
• W2788848192 cites W2152233370 @default.
• W2788848192 cites W2153270278 @default.
• W2788848192 cites W2153287313 @default.
• W2788848192 cites W2155046805 @default.
• W2788848192 cites W2166218331 @default.
• W2788848192 cites W2327965600 @default.
• W2788848192 cites W2415260769 @default.
• W2788848192 cites W2572409941 @default.
• W2788848192 doi "https://doi.org/10.4103/njcp.njcp_208_17" @default.
• W2788848192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29465053" @default.
• W2788848192 hasPublicationYear "2018" @default.
• W2788848192 type Work @default.
• W2788848192 sameAs 2788848192 @default.
• W2788848192 citedByCount "0" @default.
• W2788848192 crossrefType "journal-article" @default.
• W2788848192 hasAuthorship W2788848192A5009424032 @default.
• W2788848192 hasAuthorship W2788848192A5014640819 @default.
• W2788848192 hasAuthorship W2788848192A5031091926 @default.
• W2788848192 hasAuthorship W2788848192A5036161581 @default.
• W2788848192 hasAuthorship W2788848192A5038550193 @default.
• W2788848192 hasAuthorship W2788848192A5042747733 @default.
• W2788848192 hasAuthorship W2788848192A5070994957 @default.
• W2788848192 hasAuthorship W2788848192A5086140142 @default.
• W2788848192 hasConcept C119060515 @default.
• W2788848192 hasConcept C126322002 @default.
• W2788848192 hasConcept C2777417653 @default.
• W2788848192 hasConcept C2778248108 @default.
• W2788848192 hasConcept C2778319317 @default.
• W2788848192 hasConcept C2778534260 @default.
• W2788848192 hasConcept C2778653478 @default.
• W2788848192 hasConcept C2778917026 @default.
• W2788848192 hasConcept C71924100 @default.
• W2788848192 hasConcept C90924648 @default.
• W2788848192 hasConceptScore W2788848192C119060515 @default.
• W2788848192 hasConceptScore W2788848192C126322002 @default.
• W2788848192 hasConceptScore W2788848192C2777417653 @default.
• W2788848192 hasConceptScore W2788848192C2778248108 @default.
• W2788848192 hasConceptScore W2788848192C2778319317 @default.
• W2788848192 hasConceptScore W2788848192C2778534260 @default.
• W2788848192 hasConceptScore W2788848192C2778653478 @default.
• W2788848192 hasConceptScore W2788848192C2778917026 @default.
• W2788848192 hasConceptScore W2788848192C71924100 @default.
• W2788848192 hasConceptScore W2788848192C90924648 @default.
• W2788848192 hasIssue "2" @default.
• W2788848192 hasLocation W27888481921 @default.
• W2788848192 hasOpenAccess W2788848192 @default.
• W2788848192 hasPrimaryLocation W27888481921 @default.
• W2788848192 hasRelatedWork W2018316522 @default.
• W2788848192 hasRelatedWork W2082958329 @default.
• W2788848192 hasRelatedWork W2114415427 @default.
• W2788848192 hasRelatedWork W2121170793 @default.
• W2788848192 hasRelatedWork W2168658779 @default.
• W2788848192 hasRelatedWork W2183440600 @default.
• W2788848192 hasRelatedWork W2186202490 @default.
• W2788848192 hasRelatedWork W2300890815 @default.
• W2788848192 hasRelatedWork W2379845879 @default.
• W2788848192 hasRelatedWork W2398901473 @default.
• W2788848192 hasRelatedWork W2400626334 @default.
• W2788848192 hasRelatedWork W2416530626 @default.
• W2788848192 hasRelatedWork W2577667732 @default.
• W2788848192 hasRelatedWork W2727662168 @default.
• W2788848192 hasRelatedWork W2823419824 @default.
• W2788848192 hasRelatedWork W2899102336 @default.
• W2788848192 hasRelatedWork W2937356078 @default.
• W2788848192 hasRelatedWork W3012422487 @default.

• next